We serve Chemical Name:(R)-2-(((tert-Butoxycarbonyl)amino)methyl)-4-methylpentanoic acid CAS:132605-96-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(R)-2-(((tert-Butoxycarbonyl)amino)methyl)-4-methylpentanoic acid
CAS.NO:132605-96-0
Synonyms:(2R)-4-methyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]pentanoic acid
Molecular Formula:C12H23NO4
Molecular Weight:245.31500
HS Code:2924199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:79.12000
Exact Mass:245.16300
LogP:2.46240
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (2R)-4-methyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]pentanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2R)-4-methyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]pentanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2R)-4-methyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]pentanoic acid Use and application,(2R)-4-methyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]pentanoic acid technical grade,usp/ep/jp grade.
Related News: The new R&D People and Culture Strategy aims to make UK the most ideal place for research and innovation, led by individuals, universities and businesses, and funders. 4-(2,2-bis(4-methoxyphenyl)vinyl)-N-(4-(2,2-diphenylvinyl)phenyl)-N-phenylaniline manufacturers As part of the strategy, the government will review the research funding offer to retain, attract and support the very best researchers, innovators and their teams. 7-PENTADECENE suppliers So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off. Cholest-8-ene vendor & factory So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off.,The CDC’s Advisory Committee on Immunization Practices (ACIP) decision on Thursday came after an hours-long discussion over a handful of Guillain-Barré syndrome (GBS) cases reported after J&J’s jab. The independent group of experts were also tasked with reviewing the need for booster shots, specifically for people with compromised immune systems.
